vs
Amarin Corp plc（AMRN）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是Amarin Corp plc的1.1倍（$50.3M vs $45.1M），READING INTERNATIONAL INC净利率更高（-5.1% vs -23.3%，领先18.2%），Amarin Corp plc同比增速更快（7.0% vs -14.2%），过去两年READING INTERNATIONAL INC的营收复合增速更高（5.6% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
AMRN vs RDI — 直观对比
营收规模更大
RDI
是对方的1.1倍
$45.1M
营收增速更快
AMRN
高出21.2%
-14.2%
净利率更高
RDI
高出18.2%
-23.3%
两年增速更快
RDI
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $50.3M |
| 净利润 | $-10.5M | $-2.6M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | -1.9% |
| 净利率 | -23.3% | -5.1% |
| 营收同比 | 7.0% | -14.2% |
| 净利润同比 | 33.0% | -14.5% |
| 每股收益（稀释后） | — | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNRDI
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $50.3M | ||
| Q3 25 | $49.7M | $52.2M | ||
| Q2 25 | $72.7M | $60.4M | ||
| Q1 25 | $42.0M | $40.2M | ||
| Q4 24 | $62.3M | $58.6M | ||
| Q3 24 | $42.3M | $60.1M | ||
| Q2 24 | $67.5M | $46.8M |
净利润AMRNRDI
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-2.6M | ||
| Q3 25 | $-7.7M | $-4.2M | ||
| Q2 25 | $-14.1M | $-2.7M | ||
| Q1 25 | $-15.7M | $-4.8M | ||
| Q4 24 | $-48.6M | $-2.2M | ||
| Q3 24 | $-25.1M | $-7.0M | ||
| Q2 24 | $1.5M | $-12.8M |
毛利率AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNRDI
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -1.9% | ||
| Q3 25 | -22.4% | -0.6% | ||
| Q2 25 | -22.0% | 4.8% | ||
| Q1 25 | -39.9% | -17.2% | ||
| Q4 24 | -84.3% | 2.6% | ||
| Q3 24 | -59.5% | -0.6% | ||
| Q2 24 | -0.8% | -16.4% |
净利率AMRNRDI
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -5.1% | ||
| Q3 25 | -15.6% | -8.0% | ||
| Q2 25 | -19.4% | -4.4% | ||
| Q1 25 | -37.4% | -11.8% | ||
| Q4 24 | -78.0% | -3.8% | ||
| Q3 24 | -59.4% | -11.7% | ||
| Q2 24 | 2.3% | -27.4% |
每股收益（稀释后）AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-0.11 | ||
| Q3 25 | $-0.02 | $-0.18 | ||
| Q2 25 | $-0.03 | $-0.12 | ||
| Q1 25 | $-0.04 | $-0.21 | ||
| Q4 24 | $-0.12 | $-0.11 | ||
| Q3 24 | $-0.06 | $-0.31 | ||
| Q2 24 | $0.00 | $-0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | — | $-18.2M |
| 总资产 | $645.8M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNRDI
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $10.5M | ||
| Q3 25 | $286.6M | $8.1M | ||
| Q2 25 | $298.7M | $9.1M | ||
| Q1 25 | $281.8M | $5.9M | ||
| Q4 24 | $294.2M | $12.4M | ||
| Q3 24 | $305.7M | $10.1M | ||
| Q2 24 | $306.7M | $9.3M |
总债务AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $-18.2M | ||
| Q3 25 | $458.9M | $-12.1M | ||
| Q2 25 | $464.9M | $-7.7M | ||
| Q1 25 | $473.7M | $-8.1M | ||
| Q4 24 | $486.2M | $-4.4M | ||
| Q3 24 | $531.4M | $1.6M | ||
| Q2 24 | $551.9M | $6.5M |
总资产AMRNRDI
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $434.9M | ||
| Q3 25 | $659.8M | $435.2M | ||
| Q2 25 | $670.1M | $438.1M | ||
| Q1 25 | $655.7M | $441.0M | ||
| Q4 24 | $685.3M | $471.0M | ||
| Q3 24 | $750.6M | $495.7M | ||
| Q2 24 | $799.9M | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $4.3M |
| 自由现金流经营现金流 - 资本支出 | — | $4.1M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.9M |
8季度趋势，按日历期对齐
经营现金流AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $4.3M | ||
| Q3 25 | $-12.7M | $295.0K | ||
| Q2 25 | $16.6M | $1.6M | ||
| Q1 25 | $-12.5M | $-7.7M | ||
| Q4 24 | $-13.3M | $8.0M | ||
| Q3 24 | $-2.4M | $1.3M | ||
| Q2 24 | $-2.7M | $-10.4M |
自由现金流AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $-246.0K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $-8.0M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | — | $-1.1M | ||
| Q2 24 | — | $-10.6M |
自由现金流率AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | -19.8% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | -1.8% | ||
| Q2 24 | — | -22.7% |
资本支出强度AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.5% |
现金转化率AMRNRDI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
